Super V3 Investment Limited Partnership Jafco, 10% Owner at Eleven Biotherapeutics, Inc. (EBIO), sold 120,000 shares at $11.58 ($1.4M) on 2015-01-28, disclosed to the SEC on 2015-01-30.
Open-market sale of $1.4M EBIO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.58 | 5,000 | $58K | 4.2% |
| 2 | $11.46 | 55,000 | $630K | 45.2% |
| 3 | $11.77 | 60,000 | $706K | 50.6% |
| Total | $11.62 avg | 120,000 | $1.4M | 100% |
| Filing → |
| TCON | SELL | 2015-10-13 | $32K | — | Filing → |
| TCON | SELL | 2015-10-08 | $221K | — | Filing → |
| TCON | SELL | 2015-10-06 | $152K | — | Filing → |